Perspectives on pain management from the Veterans Health Administration and the defense health agency

Abstract: Over the past decade, the Department of Defense (DOD) and the Defense Health Agency (DHA) have collaborated with the Department of Veterans Affairs (VA) and the Veterans Health Administration (VHA) to implement a comprehensive, integrative approach to pain management aimed at minimizing opioid dependency while enhancing patient functionality and health. Central to this initiative is the stepped care model, which provides tailored pain management levels based on individual patient needs. Emphasizing the Whole Health concept, which encompasses physical, behavioral, spiritual, and socioeconomic well-being, both agencies have prioritized nonpharmacological strategies, such as yoga, acupuncture, and mindfulness practices. Ongoing research through the Pain Management Collaboratory (PMC) focuses on pragmatic clinical trials to evaluate and implement these approaches effectively in military populations. This collaborative effort seeks to transform pain management practices by addressing chronic pain as a multifaceted issue, thereby improving outcomes for active duty personnel and veterans alike.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.